The Europe genomics market size was valued at USD 9.83 billion in 2023 and it is predicted to surpass around USD 44.65 billion by 2033 with a CAGR of 16.34% from 2024 to 2033.
Genomics, the study of genomes and their interactions, has revolutionized healthcare, agriculture, and biotechnology. In Europe, the genomics market is experiencing significant growth driven by technological advancements and increasing applications across various sectors.
Key Pointers
- By Application & Technology, the functional genomics segment held the largest revenue share of 32% in 2023.
- By Application & Technology, the pathway analysis segment is estimated to expand the fastest CAGR 17.03% from 2024 to 2033
- By Deliverable, the products segment generated the maximum market share of 70% in 2023.
- By End-use, the pharmaceutical and biotechnology companies captured the maximum market share of 56% in 2023.
Get a Sample: https://www.visionresearchreports.com/report/sample/41365
Europe Genomics Market Growth Drivers
- Technological Advancements: Rapid developments in next-generation sequencing (NGS), CRISPR-Cas9 gene editing, and single-cell analysis are accelerating research capabilities.
- Healthcare Applications: Increased adoption of genomic medicine for diagnostics, precision medicine, and pharmacogenomics is enhancing patient outcomes and driving market growth.
- Agricultural Genomics: Europe is leveraging genomics to improve crop yield, disease resistance, and sustainability in agriculture, addressing food security challenges.
- Bioinformatics: Advancements in data analytics, cloud computing, and AI are transforming genomic data into actionable insights, fueling market expansion.
Europe Genomics Market Future Outlook
- Precision Medicine: Expanding applications in disease prevention, early diagnosis, and targeted therapies.
- AI and Machine Learning: Integration of AI for data analysis and predictive modeling in genomics.
- Environmental and Agricultural Genomics: Addressing climate change and sustainable agriculture through genomic solutions.
Read More@ https://www.heathcareinsights.com/data-monetization-solution-for-healthcare-providers-market/
Europe Genomics Market Top Companies
- Oxford Nanopore Technologies
- Qiagen
- Creative Biogene
- Thermo Fisher Scientific
- Illumina
- Bio-Rad Laboratories
- Danaher Corporation
- Agilent Technologies
- F. Hoffmann-La Roche Ltd.
- Eurofins Scientific Group
Europe Genomics Market Segmentation:
By Application & Technology
- Functional Genomics
- Transfection
- Real-Time PCR
- RNA Interference
- Mutational Analysis
- SNP Analysis
- Microarray Analysis
- Epigenomics
- Bisulfite Sequencing
- Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
- Methylated DNA Immunoprecipitation (MeDIP)
- High-Resolution Melt (HRM)
- Chromatin Accessibility Assays
- Microarray Analysis
- Pathway Analysis
- Bead-Based Analysis
- Microarray Analysis
- Real-time PCR
- Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
- Biomarker Discovery
- Mass Spectrometry
- Real-time PCR
- Microarray Analysis
- Statistical Analysis
- Bioinformatics
- DNA Sequencing
- Others
By Deliverables
- Products
- Instruments/Systems/Software
- Consumables & Reagents
- Services
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
- Others
By End-use
- Clinical Research
- Academic & Government Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End-uses
By Country
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- U.K.
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41365
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308